- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00682149
Effects of Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients
Effects Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients
There has been an increase in the prevalance of type 2 diabetes in developed countries in recent years. The major contributing factors have been genetic predisposition, environmental factors, and unhealthy eating habits and stress. Adverse effects on cardiovascular and renal systems after prolonged hyperglycemia bring serious burden to patients, to their families and to the society.
Oxidative stress has been defined as the imbalance between the production of reactive oxygen molecules and antioxidant protective molecules. It has been claimed that oxidative stress that the organism is exposed to and disturbance in anti-oxidant mechanisms have been important in the initiation of diabetes and its complications. Malondialdehyde is the final product of lipid peroxidation and it is an aldehyde as well. It has been accepted that malondialdehyde has been a biomarker in measuring oxidative stress.
Type 2 diabetic people who are between 40 -65 years of age will be the subjects of our study. The levels of fasting glucose, HbA1c, LDL, triglyceride, AST and ALT and also malondialdehyte, hydrogen peroxide and oxidative stress will be determined in patients blood after making them consume a 1500 calory standard diet for 2 weeks, The patients will be randomly divided into two grouos at the end of the two weeks. Group 1 will take placebo in addition to the diet, Group 2 will receive polyphenol containing capsules with pomegranate extract (500 mg), green tea extract (300 mg) and a little bit of (60 mg) vitamin C for three months. At the end of three months the measurement of biochemical parameters will be repeated.
Patients with cardiac, renal, liver disease and smokers will be excluded from the study.
Patients in both groups will have a diet rich in vegetables, three servings of fruit, maximum three slices of bread with a total calory of 1500.
In addition to these, both groups will have a weekly aerobic exercise regimen of 150 minutes conducted after breakfast.
The biochemical results of the two groups will be compared at the end of the experiment and they will be statistically evaluated.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Recruiting
- Sisli Etfal Education and Research Hospital
-
Contact:
- Tayyibe Saler, Dr
- Phone Number: (+90 505) 7734300
- Email: taybe1970@hotmail.com
-
Contact:
- Aysen Fenercioglu, Assist Prof. Dr.
- Phone Number: (+90 537) 9645751
- Email: aysenfenerci@hotmail.com
-
Sub-Investigator:
- Tayyibe Saler, Dr
-
Principal Investigator:
- Aysen Fenercioglu, Assist Prof. Dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 2 diabetic patients between 40-65 years of age will be eligible for the study
Exclusion Criteria:
- Patients with cardiac, renal, liver disease and smokers will be excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Group 1
We planned to compare a study group of 60 subjects with a placebo group of 60 subjects
|
1 tablet/day for 3 months
Other Names:
|
|
Active Comparator: Group 2
We planned to compare a study group of 60 subjects with a placebo group of 60 subjects
|
1 tablet/day for 3 months
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Amelioration of antioxidative capacity in diabetic patients by polyphenol containig antioxidants
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
treatment of type 2 diabetes by polyphenol containing antioxidants
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aysen Fenercioglu, Assist Prof. Dr., Yeditepe University Medical Faculty, Family medicine Department
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DM2-AOC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
-
University of PennsylvaniaNational Institute on Aging (NIA); American Heart AssociationRecruitingType 2 Diabetes Mellitus | Type 2 Diabetes | Type II Diabetes Mellitus | Pre-diabetes | Pre-diabetic | Type II Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2DM) | Pre-diabetic StateUnited States
Clinical Trials on PomGT (500 mg pomegranate extracts, 300 mg green tea and 60mg vitamin C)
-
Taipei Hospital, TaiwanNational Science Council, TaiwanCompleted
-
Instituto Nacional de Perinatologia Isidro Espinosa...Active, not recruitingInsulin Resistance | PostmenopausalMexico
-
Ain Shams UniversityCompleted
-
Al-Rasheed University CollegeCompletedDiabetes Mellitus, Type 2Iraq
-
Ain Shams UniversityCompletedEnd-Stage Renal Disease | Vitamin C | Erythropoietin | Oral Administration | Regular HemodialysisEgypt
-
Rajavithi HospitalCompletedPregnancy Anemia | Vitamin C AnemiaThailand
-
Seoul National University HospitalUnknownH1N1 InfluenzaKorea, Republic of
-
Helwan UniversityActive, not recruitingPost Operative Atrial FibrillationEgypt
-
University of North Carolina, Chapel HillNational Institute of Nursing Research (NINR); Sigma Theta Tau International...Completed
-
Universidade Federal do CearaConselho Nacional de Desenvolvimento Científico e Tecnológico; São José Hospital... and other collaboratorsRecruiting